Theriva Biologics, Inc.
XASE:TOVX
0.21
$0.75 - 1,000.00
$0.17 - 100.00
$0.21
$0.22
$0.21
$0.22
2.03
0.17
1339417
18736216.7
34879308.28
Chart
TendieTensor AI Analysis
Company
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Fundamentals
22
-0.040000
0.328506
100
BBG000BV6QX8
BBG001S77L07
9.60M
33.74M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own TOVX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.